In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Thomas Felix Luscher
Thomas Felix Luscher Thomas Felix Luscher

Royal Brompton and Harefield Hospital, London (United Kingdom of Great Britain & Northern Ireland)

Specialities : Interventional Cardiology , Acute Coronary Syndromes, Acute Heart Failure, Hypertension, Pharmacology and Pharmacotherapy

Professor Lüscher studied medicine at the University of Zurich and obtained the board certification in internal medicine and cardiology. He trained in cardiovascular research and in cardiology and specifically in echocardiography at the Mayo Clinic in Rochester, MN, USA and was later Professor of Pharmaco-therapy at the University of Basel, then Professor of Cardiology at the University of Berne, before assu-ming a position as Professor and Chairman of Cardiology and Director of the University Heart Center at the University Hospital Zurich and Director of the Center for Molecular Cardiology at the University of Zurich, Switzerland. He is now Director of Research, Education & Development and Consulting Cardiologist at the Royal Brompton & Harefield Hospital Trust and Professor of Cardiology at the Imperial College in London. He is an active general and interventional cardiologist with a broad clinical scope and large experience in prevention, coronary and valvular heart disease.

49 presentations from this speaker

Microbiome, risk factors and clinical cardiovascular disease.

Event : ESC Congress 2020

  • Session : Cutting Edge: the Microbiome and Cardiovascular Disease
  • Speaker : TF Luscher (London,GB)

Pathophysiology of atherosclerosis - Our current understanding.

Event : ESC Congress 2020

  • Session : Preventive Cardiology - Essential Update Part 1
  • Speaker : TF Luscher (London,GB)

The EHJ: A success story.

Event : ESC Congress 2020

  • Session : EHJ New Editor in Chief
  • Speaker : TF Luscher (London,GB)

Audience questions and answers, summary and close

Event : ESC Congress 2019

  • Session : SGLT2 inhibitors in clinical cardiology: modern-day cardiovascular management in patients with type 2 diabetes
  • Speaker : TF Luscher (London,GB)
  • Sponsored by The Boehringer Ingelheim, Eli Lilly and Company Alliance

Introduction

Event : ESC Congress 2019

  • Session : Discussing the opportunities for SGLT2 in clinical cardiology
  • Speaker : TF Luscher (London,GB)
  • Organised by PACE-CME, supported with an educational grant provided by Boehringer-Ingelheim/Lilly

Introduction

Event : ESC Congress 2019

  • Session : Expanding opportunities for SGLT2i in clinical cardiology
  • Speaker : TF Luscher (London,GB)
  • Organised by PACE-CME, supported with an educational grant provided by Boehringer-Ingelheim/Lilly

Management of acute coronary syndromes in 2019.

Event : ESC Congress 2019

  • Session : The European Heart Journal’s advances from prevention to intervention: the year in Cardiology
  • Speaker : TF Luscher (London,GB)
  • Joint with the European Heart Journal

Panel discussion

Event : ESC Congress 2019

  • Session : Expanding opportunities for SGLT2i in clinical cardiology
  • Speaker : TF Luscher (London,GB)
  • Organised by PACE-CME, supported with an educational grant provided by Boehringer-Ingelheim/Lilly

Panel discussion

Event : ESC Congress 2019

  • Session : Discussing the opportunities for SGLT2 in clinical cardiology
  • Speaker : F Zannad (Vandoeuvre,FR), TF Luscher (London,GB), C Wanner (Wuerzburg,DE), J Deanfield (,GB)
  • Organised by PACE-CME, supported with an educational grant provided by Boehringer-Ingelheim/Lilly

The future of publishing

Event : ESC Congress 2019

  • Session : From submission to sharing: How to publish your best articles in the European Heart Journal and the New England Journal of Medicine
  • Speaker : TF Luscher (London,GB)
  • Joint with the European Heart Journal

The microbiome and cardiovascular diseases.

Event : ESC Congress 2019

  • Session : Bench to bedside: therapeutic perspectives.
  • Speaker : TF Luscher (London,GB)
  • in collaboration with Basic CardioVascular Science (BCVS)

Welcome and introduction

Event : ESC Congress 2019

  • Session : SGLT2 inhibitors in clinical cardiology: modern-day cardiovascular management in patients with type 2 diabetes
  • Speaker : TF Luscher (London,GB)
  • Sponsored by The Boehringer Ingelheim, Eli Lilly and Company Alliance

Discussion - GLP-1 RA in diabetes and cardiovascular disease - What are the key opportunities for cardiology practice

Event : ESC Congress 2018

  • Session : Outcomes of GLP-1 RA in diabetes and cardiovascular disease - Discussing the key opportunities for cardiology practice
  • Speaker : TF Luscher (London,GB), L Ryden (Stockholm,SE), S Jacob (Villingen,DE)
  • Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Novo Nordisk

Discussion and summary - Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice?

Event : ESC Congress 2018

  • Session : Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice? (EBAC Accredited)
  • Speaker : TF Luscher (London,GB), J Deanfield (,GB)
  • Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Novo Nordisk

How to successfully convince your peers

Event : ESC Congress 2018

  • Session : From submission to sharing: How to publish your best articles in the European Heart Journal and the New England Journal of Medicine
  • Speaker : TF Luscher (London,GB)
  • Joint with the European Heart Journal

Introduction - Outcomes of GLP-1 RA in diabetes and cardiovascular disease - Discussing the key opportunities for cardiology practice

Event : ESC Congress 2018

  • Session : Outcomes of GLP-1 RA in diabetes and cardiovascular disease - Discussing the key opportunities for cardiology practice
  • Speaker : TF Luscher (London,GB)
  • Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Novo Nordisk

Introduction - Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice?

Event : ESC Congress 2018

  • Session : Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice? (EBAC Accredited)
  • Speaker : TF Luscher (London,GB)
  • Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Novo Nordisk

Prevention in 2018 - Inflammation.

Event : ESC Congress 2018

  • Session : The European Heart Journal’s advances from prevention to intervention: the year in Cardiology
  • Speaker : TF Luscher (London,GB)
  • Joint with the European Heart Journal

Wrap-up.

Event : ESC Congress 2018

  • Session : ESC ATLAS of Cardiology: statistics on cardiovascular disease and care
  • Speaker : C Cannon (Boston,US), TF Luscher (London,GB)

Audience Q&A - Atherosclerosis, cardiovascular risk factors and secondary prevention: are we making progress?

Event : ESC Congress 2017

  • Session : Atherosclerosis, cardiovascular risk factors and secondary prevention: are we making progress?
  • Speaker : W Koenig (Munich,DE), PM Ridker (Boston,US), TF Luscher (London,GB), P Libby (Boston,US)
  • Sponsored by Novartis Pharma AG

How to successfully convince your peers?

Event : ESC Congress 2017

  • Session : From submission to sharing: how to publish your best articles in the European Heart Journal and the New England Journal of Medicine
  • Speaker : TF Luscher (London,GB)
  • Joint with the European Heart Journal

Positioning of the topic - Inflammation and cardiovascular disease

Event : ESC Congress 2017

  • Session : Inflammation and cardiovascular disease
  • Speaker : TF Luscher (London,GB)

Summary and closing remarks - Atherosclerosis and secondary cardiovascular disease prevention: inflammation and LDL-cholesterol.

Event : ESC Congress 2017

  • Session : Atherosclerosis and secondary cardiovascular disease prevention: inflammation and low density lipoprotein (LDL)-cholesterol
  • Speaker : TF Luscher (London,GB)
  • Sponsored by Novartis Pharma AG

The European Heart Journal's Year in Cardiology: from prevention to intervention - Introduction

Event : ESC Congress 2017

  • Session : The European Heart Journal's Year in Cardiology: from prevention to intervention
  • Speaker : TF Luscher (London,GB)
  • Joint with the European Heart Journal

Welcome - Atherosclerosis and secondary cardiovascular disease prevention: inflammation and LDL-cholesterol.

Event : ESC Congress 2017

  • Session : Atherosclerosis and secondary cardiovascular disease prevention: inflammation and low density lipoprotein (LDL)-cholesterol
  • Speaker : TF Luscher (London,GB)
  • Sponsored by Novartis Pharma AG

HDL as potential therapeutic target.

Event : Frontiers in CardioVascular Biology 2016

  • Session : Biology of high-density lipoproteins: an update
  • Speaker : TF Luscher (London,GB)

How to convince successfully your peers?

Event : ESC Congress 2016

  • Session : What are the Editor's criteria for good scientific papers?
  • Speaker : TF Luscher (London,GB)
  • Meet the Editors of the European Heart Journal and New England Journal of Medicine

Mechanisms of survival in ischemic CMP.

Event : Heart Failure 2016

  • Session : Revascularisation strategies in ischemic heart failure
  • Speaker : TF Luscher (London,GB)

The European Heart Journal's Year in cardiology: from prevention to intervention - Introduction

Event : ESC Congress 2016

  • Session : The European Heart Journal's Year in Cardiology: from prevention to intervention
  • Speaker : TF Luscher (London,GB)
  • Joint with the European Heart Journal

Discussion - Cytokines and cardiovascular disease: exploring inflammation & clinical outcomes.

Event : ESC Congress 2015

  • Session : Cytokines and cardiovascular disease: exploring inflammation & clinical outcomes
  • Speaker : TF Luscher (London,GB)
  • Organised by Academic Medical Center Amsterdam Course Director: John Kastelein Supported by an unrestricted educational grant from Physicians' Academy for Cardiovascular Education

Do current clinical trials meet society needs? A journal perspective.

Event : ESC Congress 2015

  • Session : Do current clinical trials meet society needs?
  • Speaker : TF Luscher (London,GB)

How to bring your research to the light.

Event : ESC Congress 2015

  • Session : How to wake up your professional skills
  • Speaker : TF Luscher (London,GB)
  • ESC and the British Junior Cardiologists' Association

How to convince successfully your peers?

Event : ESC Congress 2015

  • Session : What are the editor’s criteria for good scientific papers? - Meet the Editors of the European Heart Journal
  • Speaker : TF Luscher (London,GB)

Introduction

Event : ESC Congress 2015

  • Session : The European Heart Journal‘s year in cardiology: from prevention to intervention
  • Speaker : TF Luscher (London,GB)

Introduction - Appraisal of therapies in angina management.

Event : ESC Congress 2015

  • Session : Appraisal of therapies in angina management
  • Speaker : TF Luscher (London,GB)
  • Organised by University Hospital Zurich Course Director: Thomas Luscher Supported by an unrestricted educational grant from SERVIER

Introduction.

Event : Heart Failure 2015

  • Session : The European Heart Journal’s / European Journal of Heart Failure’s year in Cardiology
  • Speaker : TF Luscher (London,GB)

How to convince successfully your peers?

Event : ESC Congress 2014

  • Session : What are the editor’s criteria for good scientific papers?
  • Speaker : TF Luscher (London,GB)

Introduction.

Event : ESC Congress 2014

  • Session : The European Heart Journal’s Year in Cardiology: from prevention to intervention
  • Speaker : TF Luscher (London,GB)

ODYSSEY COMBO II / ODYSSEY FH I and FH II: Discussant review

Event : ESC Congress 2014

  • Session : Hot Line: Coronary artery disease and lipids
  • Speaker : TF Luscher (London,GB)

ODYSSEY LONG TERM: Discussant review

Event : ESC Congress 2014

  • Session : Hot Line: Coronary artery disease and lipids
  • Speaker : TF Luscher (London,GB)

How to write an outstanding paper: wise words from the editor.

Event : ESC Congress 2013

  • Session : Career development session: from brainstorming to the outstanding paper
  • Speaker : TF Luscher (London,GB)

InterTAK: The International Takotsubo Registry

Event : ESC Congress 2013

  • Session : Registry Hot Line: Registries on risks, therapies and outcomes
  • Speaker : TF Luscher (London,GB)

Introduction.

Event : ESC Congress 2013

  • Session : The Best of the European Heart Journal. The year in coronary artery disease: from prevention to intervention
  • Speaker : TF Luscher (London,GB)

New understanding of plaque vulnerability.

Event : ESC Congress 2013

  • Session : Plaque regression: the new frontier in coronary artery disease
  • Speaker : TF Luscher (London,GB)
  • Organised by University Hospital Zurich / Course Director: Prof. Thomas F. Luescher / Supported by an unrestricted educational grant from SERVIER

Panel discussion: top 5 in invasive cardiology.

Event : ESC Congress 2013

  • Session : Top 5 in invasive cardiology: “Why and which patient to refer”
  • Speaker : TF Luscher (London,GB)
  • Sponsored by Medtronic

Swiss centre.

Event : ESC Congress 2013

  • Session : ESC Cardiology Quiz
  • Speaker : TF Luscher (London,GB), F Ruschitzka (Zurich,CH), M Greutmann (Zurich,CH), FC Tanner (Zurich,CH), O Gaemperli (Zurich,CH), J Steffel (Meilen,CH)

The role of inflammation.

Event : ESC Congress 2013

  • Session : Spotlight on the unstable plaque
  • Speaker : TF Luscher (London,GB)

What are the best intermediate endpoints?

Event : ESC Congress 2013

  • Session : Outcome measures in secondary prevention - what and how to measure?
  • Speaker : TF Luscher (London,GB)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are